The health management to the pregnant women of chronic hepatitis B

( views:, downloads: )
Author:
HE Wei-ping()
Journal Title:
CHINESE JOURNAL OF HEALTH MANAGEMENT
Issue:
Volume 2, Issue 04, 2008
DOI:
Key Word:

Abstract:

  • [1]李婧,周荣.感染乙型肝炎病毒孕妇心理社会干预.当代护士(学术版),2007,(10):86-87.
  • [2]项桂菊,孙健伟,江水清,等.拉米夫定联合主被动免疫干预乙型肝炎病毒母婴传播的疗效评价.中国实用医药,2007,2:14-16.
  • [3]Johnson MA,Moore KH,Yuen GJ,et al.Clinical pharmacokinetics of lamivudine.Clin Pharmacokinet,1999,36:41-66.
  • [4]Su GG,Pan KH,Zhao NF,et al.Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy.World J Gastreenterol,2004,10:910-912.
  • [5]施敏凤,李小毛,贺晶,等.拉米夫定阻断乙型肝炎病毒宫内感染的研究.中国综合临床,2005,21:77-78.
  • [6]van Zonneveld M,van Nunen AB,Niestors HG,et al.Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection.J Viral Hepat,2003,10:294-297.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn